| Company Name | Exchange | Ticker | Market Cap (Mn) |
Last Price | Last Volume | Price Return (1-Day) |
Price Return (5-Days) |
52-Week High | 52-Week Low |
| Synthetic Biologics Inc | NYSE | SYN | 114.6 | 1.96 | 4,851,413 | 34.3% | 29.8% | 3.64 | 0.95 |
| Aurora Spine Corp | TSXV | ASG | 40.6 | 2.59 | 107,599 | 17.7% | 40.0% | 6.60 | 1.00 |
Note: Market Cap & Last Price are in their respective currencies
Synthetic Biologics Inc (NYSE: SYN), formerly Adeona Pharmaceuticals, Inc., a biotechnology company focused on the development of synthetic deoxyribonucleic acid (DNA)-based therapeutics and disease-modifying medicines for serious illnesses, was the top performer in the U.S. health sector after climbing 34.3% Tuesday on no news and ended at $1.96 while recording huge trading volumes of 4.8 million shares. Yesterday, the stock broke all the key technical resistance levels of 30-day, 50-day and 200-day DMAs (Daily Moving Average) of $1.61, $1.53 and $1.84 respectively. During the past 5-trading sessions, the stock gained 29.8% with daily average trading volumes of 1.5 million shares, while the stock accumulated over 14% in the past one month with daily average trading volumes of 614,031 shares. The stock is up 28% year-to-date.
Shares of Aurora Spine Corp (TSX-V: ASG), a Canada-based development-stage company engaged in the business of development and commercialization of interspinous fusion systems and devices, jumped 17.7% yesterday on the announcement of its first U.S. surgery using the ZIP Graft (TM) pre-packaged sterile bone dowel performed at Madison County Hospital in London, Ohio by Dr. Won Song. The stock breached the short term 30-day DMA of C$2.58 and closed yesterday at C$2.59 while recording significant volumes of 107,599 shares. The stock witnessed a strong upward share price momentum after rallying more than 15% in each of the last two consecutive days with significant numbers of shares exchanging hands. During the past five trading sessions, the stock gained 40% with daily average trading volumes of 122,736 shares compared with the past one month average trading volumes of 42,252 shares.
